NCT06212414

Brief Summary

The purpose of this research project is to optimize the Mind programme for women with breast cancer, taking into consideration the results from its pilot study, and to testits efficacy and cost-effectiveness through a 3-arm randomized controlled trial

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
153

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 3, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 18, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 18, 2024

Status Verified

January 1, 2024

Enrollment Period

1.4 years

First QC Date

January 3, 2024

Last Update Submit

January 15, 2024

Conditions

Keywords

Mental healthQuality of lifeCost-effectivenessMindfulnessCompassion Focused TherapyAcceptance and Commitment Therapy

Outcome Measures

Primary Outcomes (1)

  • Change from baseline cancer-specific quality of life at post-treatment and 6-month follow-up

    EORTC QLQ-C30

    Baseline, post-treatment (2 months after baseline) and 6-month follow-up

Secondary Outcomes (7)

  • Change from baseline depressive symptoms and anxiety severity at post-treatment and 6-month follow-up

    Baseline, post-treatment (2 months after baseline) and 6-month follow-up

  • Change from baseline psychological flexibility at post-treatment and 6-month follow-up

    Baseline, post-treatment (2 months after baseline) and 6-month follow-up

  • Change from baseline self-compassion and mindfulness at post-treatment and 6-month follow-up

    Baseline, post-treatment (2 months after baseline) and 6-month follow-up

  • Change from baseline health-related quality of life at post-treatment and 6-month follow-up

    Baseline, post-treatment (2 months after baseline) and 6-month follow-up

  • Change from baseline consumption of resources and costs in breast cancer at post-treatment and 6-month follow-up

    Baseline, post-treatment (2 months after baseline) and 6-month follow-up

  • +2 more secondary outcomes

Study Arms (3)

Mind programme

EXPERIMENTAL

This group will receive the Mind programme. This intervention comprises 8 weekly group sessions, with the duration of 120 minutes each, to be delivered via Zoom. Integration of Acceptance and Commitment Therapy, mindfulness and Compassion Focused Therapy components, adapted to women with breast cancer. All participants will continue on receiving the recommended medical treatment for their clinical diagnosis.

Behavioral: Mind Programme

Support group

ACTIVE COMPARATOR

This group will receive a 8-week support group intervention (weekly sessions, with the duration of 120 minutes each), via Zoom. All participants will continue on receiving the recommended medical treatment for their clinical diagnosis.

Behavioral: Support Group

Waiting list (Treatment As Usual / No psychological intervention)

NO INTERVENTION

This group will receive the (psychological) treatment as usual in Portugal (no treatment), besides the recommended medical treatment for their clinical diagnosis. At the end of this research project, the intervention that proves to be most efficacious will be offered to participants from the waiting list condition.

Interventions

Mind ProgrammeBEHAVIORAL

Intervention based on Acceptance and Commitment Therapy, mindfulness, and compassion approaches

Mind programme
Support GroupBEHAVIORAL

This intervention promotes the sharing of cancer-related experiences, active listening, and a sense of community between participants

Support group

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age between 18-70;
  • primary diagnosis of BC (stages between I and III);
  • having a scheduled radiotherapy treatment starting within 2 months, currently undergoing radiotherapy treatment, or having finished radiotherapy treatment no more than 6 months prior, at any hospital in Portugal;
  • able to understand and answer to self-report questionnaires in Portuguese;
  • having access to a computer or tablet with internet.

You may not qualify if:

  • currently undergoing any form of psychological intervention;
  • current diagnosis of severe psychiatric illness (psychotic disorder, bipolar disorder, substance abuse, and personality disorder) or suicidal ideation;
  • diagnosis of neurological disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Research in Neuropsychology and Cognitive and Behavioral Intervention, University of Coimbra

Coimbra, 3000-115 Coimbra, Portugal, Portugal

RECRUITING

Related Publications (1)

  • Trindade IA, Soares A, Skvarc D, Carreiras D, Pereira J, Lourenco O, Sampaio F, de Sousa B, Martins TC, Boaventura P, Marta-Simoes J; Mind Project Team; Moreira H. Efficacy and cost-effectiveness of an ACT and compassion-based intervention for women with breast cancer: study protocol of two randomised controlled trials 1. Trials. 2025 Jan 3;26(1):5. doi: 10.1186/s13063-024-08626-4.

MeSH Terms

Conditions

Psychological Well-Being

Interventions

Self-Help Groups

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Central Study Contacts

Inês Trindade, PhD

CONTACT

Helena Moreira, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 3, 2024

First Posted

January 18, 2024

Study Start

October 1, 2023

Primary Completion

March 1, 2025

Study Completion

December 1, 2025

Last Updated

January 18, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations